Insmed, Inc. (INSM)
176.34
-1.54
(-0.87%)
USD |
NASDAQ |
Dec 29, 16:00
176.34
0.00 (0.00%)
After-Hours: 07:52
Insmed EPS Diluted (Quarterly): -1.747 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Biogen, Inc. | 3.171 |
| Pfizer Inc. | 0.6197 |
| Nektar Therapeutics | -1.875 |
| CorMedix, Inc. | 1.259 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -370.02M |
| Revenue (Quarterly) | 142.34M |
| Total Expenses (Quarterly) | 512.36M |
| Enterprise Value | 36.67B |
| Gross Profit Margin (Quarterly) | 78.29% |
| Profit Margin (Quarterly) | -260.0% |
| Earnings Yield | -3.51% |
| Normalized Earnings Yield | -3.180 |